Breaking News
If housing prices had simply followed income growth since 1970
According to INSEE data, France is now channeling 57.2% of its GDP through government spending
Power is moving eastwards and westerners are talking about how great it is...
Agricultural commodities are now breaking out decisively from nearly 20-year resistance.
Top Tech News
Researcher wins 1 bitcoin bounty for 'largest quantum attack' on underlying tech
Interceptor-Drone Arms-Race Emerges
A startup called Inversion has introduced Arc, a space-based vehicle...
Mining companies are using cosmic rays to find critical minerals
They regrew a severed nerve - by shortening a bone.
New Robot Ants Work Like Real Insects To Build And Dismantle On Their Own
Russian scientists 'are developing the world's first drug to delay ageing' months after
Sam Altman's World ID Expands Biometric Identity Checks
China Tests Directed Energy Beam That Recharges Drones Mid-Flight
Jurassic Park might arrive sooner than expected, just with Dinobots.
Scientists Are Racing to Create Synthetic Blood in the Wake of Mass Tragedies
The Las Vegas shooting is the latest reminder that human blood isn't enough for massive, unexpected transfusions.
In the aftermath of the Las Vegas mass shooting on Sunday, hundreds of people lined up to give blood at a handful of donation centers in the area. It was a heartening scene—people hoping to help in any way they could. But if science lives out its promise, it will one day be an obsolete one.
Scientists have been working on creating synthetic blood for years now. The hope is that this substance will have a longer shelf life than human blood—which can only be refrigerated for 42 days—and eventually can be packaged and stored for use in emergencies. If this works, thousands of lives could be saved every year.
"People can't show up fast enough and then the system can't draw their blood fast enough to meet the need," said Allan Doctor, a physician and researcher at the Washington University in St. Louis. "Pulse nightclub, Boston Marathon, now Vegas—all of these are situations where there's a sudden unpredictable need for massive transfusion."
Doctor's lab has been working to create a blood substitute called ErythroMer, comprised of human hemoglobin, sourced from the red blood cells in expired blood at blood banks, and a synthetic polymer. This synthetic blood is actually a dehydrated powder, which would allow it to be stored for years, rather than weeks, and easily transported. Doctor envisions that it could eventually be packaged along with purified water so that doctors or EMTs could mix it when they needed to use it on a patient.
ErythroMer is still in the planning stages. It has only been tested on animals, and Doctor predicts that the team is about three to five years from the first human trials. Following that, it will need FDA approval, and then healthcare workers will need to be trained to use it properly to avoid infections. "It's important for us to have a bulletproof delivery system," Doctor told me. He predicts that it will be available in six to 10 years if the trials are successful, and if they can make a cost-effective formula.